Cargando…

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population

BACKGROUND: Numerous studies validated frequent glucose dysfunction in patients with acute pancreatitis (AP). However, the prevalence of new-onset diabetes in individuals after a first episode of AP varies widely among previous studies. This study aims to determine the incidence of post-acute pancre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yingqi, Zhang, Jun, Yang, Ting, Sun, Jinfang, Hou, Jiaying, Chen, Zhiwei, Yu, Xuehua, Yuan, Xuelu, Lu, Xuejia, Xie, Ting, Yu, Ting, Su, Xianghui, Liu, Gaifang, Zhang, Chi, Li, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174455/
https://www.ncbi.nlm.nih.gov/pubmed/35692404
http://dx.doi.org/10.3389/fendo.2022.903731
_version_ 1784722236909813760
author Lv, Yingqi
Zhang, Jun
Yang, Ting
Sun, Jinfang
Hou, Jiaying
Chen, Zhiwei
Yu, Xuehua
Yuan, Xuelu
Lu, Xuejia
Xie, Ting
Yu, Ting
Su, Xianghui
Liu, Gaifang
Zhang, Chi
Li, Ling
author_facet Lv, Yingqi
Zhang, Jun
Yang, Ting
Sun, Jinfang
Hou, Jiaying
Chen, Zhiwei
Yu, Xuehua
Yuan, Xuelu
Lu, Xuejia
Xie, Ting
Yu, Ting
Su, Xianghui
Liu, Gaifang
Zhang, Chi
Li, Ling
author_sort Lv, Yingqi
collection PubMed
description BACKGROUND: Numerous studies validated frequent glucose dysfunction in patients with acute pancreatitis (AP). However, the prevalence of new-onset diabetes in individuals after a first episode of AP varies widely among previous studies. This study aims to determine the incidence of post-acute pancreatitis diabetes mellitus (PPDM-A) in Chinese people and further identify potential risk factors that influence diabetes development in patients with AP. METHODS: This was a multi-center retrospective cohort study including 6009 inpatients with a first attack of AP. A total of 1804 patients with AP without known endocrine pancreatic disorders or other pancreatic exocrine diseases were eligible for analysis. Data was collected from medical records by hospital information system and telephone follow-ups after discharge. The multiple logistic regression analysis was established to evaluate the potential influencing factors of PPDM-A. RESULTS: The prevalence of newly diagnosed diabetes after a first episode of AP in China was 6.2%. Data showed that patients who developed PPDM-A were more likely to be younger (X(2) = 6.329, P = 0.012), experienced longer hospital stays (X(2) = 6.949, P = 0.008) and had a higher frequency of overweight or obesity (X(2) = 11.559, P = 0.003) compared to those with normal glycemia. The frequency of stress hyperglycemia on admission (X(2) = 53.815, P < 0.001), hyperlipidemia (X(2) = 33.594, P < 0.001) and non-alcoholic fatty liver disease (NAFLD) (X(2) = 36.335, P < 0.001) were significantly higher among individuals with PPDM-A compared with control group. Also, patients with PPDM-A were more likely to be hyperlipidemic AP (X(2) = 16.304, P = 0.001) and show a higher degree of severity (X(2) = 7.834, P = 0.020) and recurrence rate (X(2) = 26.908, P < 0.001) of AP compared to those without diabetes. In addition, multiple logistic regression analysis indicated that stress hyperglycemia, hyperlipidemia, NAFLD and repeated attacks of AP were the independent influence factors for developing PPDM-A. CONCLUSION: Our study first demonstrated the prevalence of secondary diabetes in Chinese patients after AP. The disorder of glucose metabolism in individuals with AP should be regularly evaluated in clinical practice. Further studies are needed to verify the relationship between liver and pancreas in keeping glucose homeostasis under AP condition.
format Online
Article
Text
id pubmed-9174455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91744552022-06-09 Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population Lv, Yingqi Zhang, Jun Yang, Ting Sun, Jinfang Hou, Jiaying Chen, Zhiwei Yu, Xuehua Yuan, Xuelu Lu, Xuejia Xie, Ting Yu, Ting Su, Xianghui Liu, Gaifang Zhang, Chi Li, Ling Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Numerous studies validated frequent glucose dysfunction in patients with acute pancreatitis (AP). However, the prevalence of new-onset diabetes in individuals after a first episode of AP varies widely among previous studies. This study aims to determine the incidence of post-acute pancreatitis diabetes mellitus (PPDM-A) in Chinese people and further identify potential risk factors that influence diabetes development in patients with AP. METHODS: This was a multi-center retrospective cohort study including 6009 inpatients with a first attack of AP. A total of 1804 patients with AP without known endocrine pancreatic disorders or other pancreatic exocrine diseases were eligible for analysis. Data was collected from medical records by hospital information system and telephone follow-ups after discharge. The multiple logistic regression analysis was established to evaluate the potential influencing factors of PPDM-A. RESULTS: The prevalence of newly diagnosed diabetes after a first episode of AP in China was 6.2%. Data showed that patients who developed PPDM-A were more likely to be younger (X(2) = 6.329, P = 0.012), experienced longer hospital stays (X(2) = 6.949, P = 0.008) and had a higher frequency of overweight or obesity (X(2) = 11.559, P = 0.003) compared to those with normal glycemia. The frequency of stress hyperglycemia on admission (X(2) = 53.815, P < 0.001), hyperlipidemia (X(2) = 33.594, P < 0.001) and non-alcoholic fatty liver disease (NAFLD) (X(2) = 36.335, P < 0.001) were significantly higher among individuals with PPDM-A compared with control group. Also, patients with PPDM-A were more likely to be hyperlipidemic AP (X(2) = 16.304, P = 0.001) and show a higher degree of severity (X(2) = 7.834, P = 0.020) and recurrence rate (X(2) = 26.908, P < 0.001) of AP compared to those without diabetes. In addition, multiple logistic regression analysis indicated that stress hyperglycemia, hyperlipidemia, NAFLD and repeated attacks of AP were the independent influence factors for developing PPDM-A. CONCLUSION: Our study first demonstrated the prevalence of secondary diabetes in Chinese patients after AP. The disorder of glucose metabolism in individuals with AP should be regularly evaluated in clinical practice. Further studies are needed to verify the relationship between liver and pancreas in keeping glucose homeostasis under AP condition. Frontiers Media S.A. 2022-05-25 /pmc/articles/PMC9174455/ /pubmed/35692404 http://dx.doi.org/10.3389/fendo.2022.903731 Text en Copyright © 2022 Lv, Zhang, Yang, Sun, Hou, Chen, Yu, Yuan, Lu, Xie, Yu, Su, Liu, Zhang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Lv, Yingqi
Zhang, Jun
Yang, Ting
Sun, Jinfang
Hou, Jiaying
Chen, Zhiwei
Yu, Xuehua
Yuan, Xuelu
Lu, Xuejia
Xie, Ting
Yu, Ting
Su, Xianghui
Liu, Gaifang
Zhang, Chi
Li, Ling
Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title_full Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title_fullStr Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title_full_unstemmed Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title_short Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
title_sort non-alcoholic fatty liver disease (nafld) is an independent risk factor for developing new-onset diabetes after acute pancreatitis: a multicenter retrospective cohort study in chinese population
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174455/
https://www.ncbi.nlm.nih.gov/pubmed/35692404
http://dx.doi.org/10.3389/fendo.2022.903731
work_keys_str_mv AT lvyingqi nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT zhangjun nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT yangting nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT sunjinfang nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT houjiaying nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT chenzhiwei nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT yuxuehua nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT yuanxuelu nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT luxuejia nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT xieting nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT yuting nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT suxianghui nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT liugaifang nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT zhangchi nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation
AT liling nonalcoholicfattyliverdiseasenafldisanindependentriskfactorfordevelopingnewonsetdiabetesafteracutepancreatitisamulticenterretrospectivecohortstudyinchinesepopulation